Recent clinical evidence shows that acute, severe exacerbations of asthma are associated with recruitment and activation of neutrophils in the airways. There is also experimental evidence from rodents that T-lymphocytes are involved in the recruitment of neutrophils following allergen challenge in sensitised airways. This review addresses the potential role of neutrophils and the cytokine interleukin-17 (IL-17) in severe asthma. IL-17 is produced and released as a free protein from T-lymphocytes of the memory (CD45RO+) subset. Evidence from rats in vivo suggests that IL-17 can recruit and activate neutrophils in the airways; the recruitment is mediated by the rat correlate to the neutrophil chemoattractant interleukin-8 (IL-8) macrophage inflammatory protein-2 (MIP-2). Endogenous peptidases modulate neutrophil recruitment by acting on NK-1 receptors in rat airways in vivo. Human bronchial epithelial cells in vitro respond to stimulation with IL-17 by increasing the production and release of the human neutrophil chemoattractant IL-8. This release of IL-8 is functionally significant; it causes neutrophil chemotaxis in vitro. Furthermore, this IL-8 release is sensitive to a glucocorticoid and is potentiated by the pro-inflammatory cytokine, tumour necrosis factor-alpha (TNF-α) in vitro. In addition, IL-17 stimulates human bronchial epithelial cells in vitro to release the neutrophil-activating factor IL-6. This effect of IL-17 on IL-6, and IL-8 is in part mediated via mitogen-activated protein kinases. In conclusion, as indicated in rat airways in vivo and in human bronchial epithelial cells in vitro, IL-17 may constitute a link between the activation of certain T-lymphocytes and mobilisation of neutrophils in the airways, via induced release of C-X-C chemokines and tachykinins. Further studies are required to answer the question whether free, soluble IL-17 protein plays this role in the airways of patients with severe asthma.

Keywords:
Airway, Asthma, Chemokines, Chemotaxis, Cytokines, Elastase, IL-6, IL-8, Lung, MIP-2
1.
Fahy JV, Kim KW, Liu J, Boushey HA: Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol 1995;95:843–852.
2.
Ordonez CL, Shaughnessy TE, Matthay MA, Fahy JV: Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma. Clinical and biological significance. Am J Respir Crit Care Med 2000;161:1185–1190.
3.
Laitinen LA, Laitinen A, Haahtela T: Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis 1993;147:697–704.
4.
Lamblin C, Gosset P, Tillie-Leblond I, Saulnier F, Marquette C-H, Wallaert B, Tonnel AB: Bronchial neutrophilia in patients with noninfectious status asthmaticus. Am J Respir Crit Care Med 1998;157:394–402.
5.
Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ: Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 1999;160:1532–1539.
6.
Vulcano M, Alves Rosa MF, Minnucci FS, Chernavsky AC, Isturiz MA: N-formyl-methionyl-leucyl-phenylalanine (fMLP) inhibits tumour necrosis factor-alpha (TNF-α) production on lipopolysaccharide (LPS)-stimulated human neutrophils. Clin Exp Immunol 1998;113:39–47.
7.
Keatings VM, Collins PD, Scott DM, Barnes PJ: Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996;153:530–534.
8.
Hessel EM, Van Oosterhout AJ, Van Ark I, Van Esch B, Hofman G, Van Loveren H, Savelkoul HF, Nijkamp FP: Development of airway hyperresponsiveness is dependent on interferon-gamma and independent of eosinophil infiltration. Am J Resp Crit Care Med 1997;16:325–334.
9.
Jorens PG, Richman-Eisenstadt JBY, Housset BP, Graf PD, Ueki I, Olesch J, Nadel JA: Interleukin-8 induces neutrophil accumulation but not protease secretion in the canine trachea. Am J Physiol 1992;263:L708–L713.
10.
Lindén A: Increased interleukin-8 release by beta-adrenoceptor activation in human transformed bronchial epithelial cells. Br J Pharmacol 1996;119:402–406.
11.
Xiu Q, Fujimura M, Nomura M, Saito M, Matsuda T, Akao N, Kondo K, Matsushima K: Bronchial hyperresponsiveness and airway neutrophil accumulation induced by interleukin-8 and the effect of the thromboxane A2 antagonist S-1452 in guinea-pigs. Clin Exp Allergy 1995;25:51–59.
12.
Massion P, Lindén A, Inoue H, Mathy M, Grattan KM, Nadel JA: Dimethyl sulfoxide decreases interleukin-8-mediated neutrophil recruitment in the airways. Am J Physiol 1996;271:L838–L843.
13.
Watanabe M, Kaihatsu T, Miwa M, Maeda T: Ca2+/calmodulin-dependent protein kinase II inhibitors potentiate superoxide production in polymorphonuclear leukocytes. J Pharm Pharmacol 1999;51:295–300.
14.
Page SM, Gleich GJ, Roebuck KA, Thomas LL: Stimulation of neutrophil interleukin-8 production by eosinophil granule major basic protein. Am J Respir Cell Mol Biol 1999;21:230–237.
15.
Hamid Q, Song Y, Kotsimbos TC, Minshall E, Bai TR, Hegele RG, Hogg JC: Inflammation of small airways in asthma. J Allergy Clin Immunol 1997;100:44–51.
16.
Cortijo J, Villagrasa V, Pons R, Berto L, Mart-Cabrera M, Martinez-Losa M, Domenech T, Beleta J, Morcillo EJ: Bronchodilator and anti-inflammatory activities of glaucine: In vitro studies on human airway smooth muscle and polymorphonuclear leukocytes. Br J Pharmacol 1999;127:1641–1651.
17.
Schuster A, Ueki I, Nadel JA: Neutrophil elastase stimulates tracheal submucosal gland secretion that is inhibited by ICI 200,355. Am J Physiol 1992;262:L86–L91.
18.
Vignola AM, Bonanno A, Mirabella A, Riccobond L, Mirabella F, Profita M, Bellia V, Bousquet J, Bonsignore G: Increased level of elastase and alpha 1-antitrypsin in sputum of asthmatic patients. Am J Respir Crit Care Med 1998;157:505–511.
19.
Nadel JA, Takeyama K, Augusti C: Role of neutrophil elastase in hypersecretion in asthma. Eur Respir J 1999;13:190–196.
20.
Matsumoto K, Aizawa H, Inoue H, Koto H, Nakano H, Hara N: Role of neutrophil elastase in ozone-induced airway responses in guinea-pigs. Eur Respir J 1999;14:1088–1094.
21.
Chen XJ, Hedlund LW, Moller HE, Chawla MS, Maronpot RR: Detection of emphysema in rat lungs by using magnetic resonance measurements of 3He diffusion. Proc Natl Acad Sci USA 2000;10:11478–11481.
22.
Zhu YK, Liu XD, Skold CM, Umino T, Wang HJ, Spurzem JR, Kohy RF, Rennard SI: Synergistic neutrophil elastase-cytokine interaction degrades collagen in three dimensional culture. Am J Physiol Lung Cell Mol Physiol 2000;281:L868–L878.
23.
Sampson AP: The role of eosinophils and neutrophils in inflammation. Clin Exp Allergy 2000;30:22–27.
24.
Wenzel SE, Schwartz LB, Langmack EL, Halliday JL, Trudeau JB, Gibbs RL, Chu HW: Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am Rev Respir Crit Care Med 1999;160:1001–1008.
25.
Amin K, Ludviksdottir D, Janson C, Nettelbladt O, Björnsson E, Roomans GM, Boman G, Seveus L, Venge P: Inflammation and structural changes in the airways of patients with atopic and non-atopic asthma. Am J Respir Crit Care Med 2000;162:2295–2301.
26.
Mazarella G, Grella E, D’Auria D, Paciocco G, Perna F, Petillo O, Peluso G: Phenotypic features of alveolar monocytes/macrophages and IL-8 gene activation by IL-1 and TNF-α in asthmatic patients. Allergy 2000;55:36–41.
27.
Marini M, Vittori E, Hollemborg J, Mattoli S: Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony-stimulation factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma. J Allergy Clin Immunol 1992;89:1001–1009.
28.
Walker C, Kaegi MK, Braun P, Blaser K: Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J. Allergy Clin Immunol 1991;88:935–942.
29.
Gavett SH, Chen X, Finkelman F, Wills-Karp M: Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am J Respir Cell Mol Biol 1994;10:587–593.
30.
Renzi PM, Yang JP, Diamantstein T, Martin JG: Effects of depletion of cells bearing the interleukin-2 receptor on immunoglobulin production and allergic airway responses in the rat. Am J Respir Crit Care Med 1996;153:1214–1221.
31.
Nakajima H, Iwamoto I, Tomoe S, Matsumura R, Tomioka H, Takatsu K, Yoshida S: CD4+ T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. Am Rev Respir Dis 1992;146:374–377.
32.
Cieslewics G, Tomkinson A, Adler A, Duez C, Schwarze J, Takeda K, Larson KA, Lee JJ, Irvin CG, Gelfand EW: The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophil infiltration. J Clin Invest 1999;104:301–308.
33.
Tillie-Leblond I, Hammad H, Desurmont S, Pugin J, Wallaert B, Tonnel AB, Gosset P: CC chemokines and interleukin-5 in bronchial lavage fluid from patients with status asthmaticus. Potential implications in eosinophil recruitment. Am J Respir Crit Care Med 2000;162:586–592.
34.
Leckie MJ, ten Brink A, Khan J, Diamant Z, O’Connor BJ, Walls CM, Mathur AK, Cowley HC, Chung KF, Djukanovic R, Hansel TT, Holgate ST, Sterk PJ, Barnes PJ: Effects of an interleukin-5 blocking monoclonal antibody on eosinophils. Lancet 2000;356:2114–2116.
35.
Fossiez F, Banchereau J, Murray R, Van Kooten C, Garrone P, Lebecque S: Interleukin-17. Int Rev Immunol 1998;16:541–551.
36.
Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Spriggs MK, Armitage RJ: Human IL-17:a novel cytokine derived from T cells. J Immunol 1995;155:5483–5486.
37.
Spriggs MK: Interleukin-17 and its receptor. J Clin Immunol 1997;17:366–369.
38.
Aarvak T, Chabaud M, Miossec P, Natvig JB: IL-17 is produced by some proinflammatory TH1/Th0 cells but not Th2 cells. J Immunol 1999;162:1246–1251.
39.
Shin H, Benbernou N, Esnault S, Guenounou M: Expression of IL-17 in human memory CD45RO+ T lymphocytes and its regulation by protein kinase A pathway. Cytokine 1999;11:257–266.
40.
Yao Z, Spriggs M, Derry J, Strockbine L, Park L, VandenBos T, Zappone J, Painter S, Armitage R: Molecular characterisation of the human interleukin (IL)-17 receptor. Cytokine 1997;9:794–800.
41.
Yao Z, Fanslow FC, Seldin MF, Rousseau AM, Painter SL, Comeau MR, Cohen JI, Spriggs MK: Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 1995;3:811–821.
42.
Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C, Pin JJ, Garrone P, Garcia E, Saeland S, Blanchard D, Gaillard C, Mahapatra BD, Rouvier E, Golstein P, Banchereau J, Lebecque S: T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 1996;183:2593–2603.
43.
Laan M, Lötvall J, Chung KF, Lindén A: IL-17-induced cytokine release in human bronchial epithelial cells in vitro: Role of mitogen-activated protein (MAP) kinases. Br J Pharmacol 2001;133:200–206.
44.
Laan M, Cui ZH, Hoshino H, Lötvall J, Sjöstrand M, Gruenert D, Skoogh BE, Lindén A: Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 1999;162:2347–2352.
45.
Molet S, Hamid QA, Davoine F, Nutku E, Taha R, Page N, Olivenstein R, Elias J, Chakir J: Interleukin-17 is increased in asthmatic airways and induces human fibroblasts to produce cytokines. J Allergy Clin Immunol 2001;108:103–109.
46.
Jovanovic DV, Di Battista JA; Martel-Pelletier J, Jolicœur FC, He Y, Zhang M, Mineau F, Pelletier JP: IL-17 stimulates the production and expression of pro-inflammatory cytokines IL-β and TNF-α by human macrophages. J Immunol 1998;160:3513–3521.
47.
Hoshino H, Lötvall J, Skoogh BE, Lindén A: Neutrophil recruitment by IL-17 into rat airways in vivo: Role of tachykinins. Am J Respir. Crit Care Med 1999;159:1423–1428.
48.
Hoshino H, Laan M, Sjöstrand M, Lötvall J, Skoogh BE, Lindén A: Increased elastase and myeloperoxidase activity associated with neutrophil recruitment by IL-17 in airways in vivo. J Allergy Clin Immunol 2000;105:143–149.
49.
Barnes PJ, Pedersen S: Efficacy and safety of inhaled steroids in asthma. Am Rev Respir Dis 1993;148:S1–S26.
50.
Lindén A, Hoshino H, Laan M: Airway neutrophils and interleukin-17. Eur Respir J 2000;15:973–977.
51.
Tillie-Leblond I, Pugin J, Marquette CH, Lamblin C, Saulnier F, Brichet A, Wallaert B, Tonnel AB, Gosset P: Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. Am J Respir Crit Care Med 1999;159:487–494.
52.
De Sanctis GT, Itoh A, Green FHY, Qin A, Kimura T, Grobholz JK, Martin TR, Maki T, Drazen JM: T-lymphocytes regulate genetically determined airway hyperresponsiveness in mice. Nature Med 1997;4:460–462.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.